Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dorithricin lozenges in acute pharyngitis
2016-003962-24Phase 4Completed
- Sponsor
- Medice
- Start
- Nov 2016
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute pharyngitis comparing Dorithricin lozenges with Placebo lozenges (2 arms). Primary endpoint: Total responders at 72 hours. Started Nov 2016; status: completed.
02
Drugs
tyrothricin + benzalkonium chloride + benzocaine
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on 2016-003962-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003962-24.